BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 31530771)

  • 1. [Genomic Analysis and Immunotherapy by Liquid Biopsy].
    Iinuma H
    Gan To Kagaku Ryoho; 2019 Sep; 46(9):1361-1366. PubMed ID: 31530771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquid biopsy in breast cancer: A comprehensive review.
    Alimirzaie S; Bagherzadeh M; Akbari MR
    Clin Genet; 2019 Jun; 95(6):643-660. PubMed ID: 30671931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using circulating cell-free DNA to monitor personalized cancer therapy.
    Oellerich M; Schütz E; Beck J; Kanzow P; Plowman PN; Weiss GJ; Walson PD
    Crit Rev Clin Lab Sci; 2017 May; 54(3):205-218. PubMed ID: 28393575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis, Monitoring, and Prognosis of Liquid Biopsy in Cancer Immunotherapy.
    Kong W; Chen T; Li Y
    Methods Mol Biol; 2023; 2695():127-143. PubMed ID: 37450116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liquid biopsy and PCR-free ultrasensitive detection systems in oncology (Review).
    Finotti A; Allegretti M; Gasparello J; Giacomini P; Spandidos DA; Spoto G; Gambari R
    Int J Oncol; 2018 Oct; 53(4):1395-1434. PubMed ID: 30085333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular Vesicles in Oncology: from Immune Suppression to Immunotherapy.
    Srivastava A; Rathore S; Munshi A; Ramesh R
    AAPS J; 2021 Feb; 23(2):30. PubMed ID: 33586060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urine-Based Liquid Biopsy for Nonurological Cancers.
    Jain S; Lin SY; Song W; Su YH
    Genet Test Mol Biomarkers; 2019 Apr; 23(4):277-283. PubMed ID: 30986103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liquid biopsy in ovarian cancer: the potential of circulating miRNAs and exosomes.
    Giannopoulou L; Zavridou M; Kasimir-Bauer S; Lianidou ES
    Transl Res; 2019 Mar; 205():77-91. PubMed ID: 30391474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Introduction and Clinical Application of Cell-Free Tumor DNA.
    Li J; Liu R; Huang C; Chen S; Xu M
    Methods Mol Biol; 2018; 1754():45-65. PubMed ID: 29536437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liquid Biopsy: An Evolving Paradigm for Non-invasive Disease Diagnosis and Monitoring in Medicine.
    Adhit KK; Wanjari A; Menon S; K S
    Cureus; 2023 Dec; 15(12):e50176. PubMed ID: 38192931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-Free DNA in the Liquid Biopsy Context: Role and Differences Between ctDNA and CTC Marker in Cancer Management.
    Fici P
    Methods Mol Biol; 2019; 1909():47-73. PubMed ID: 30580422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liquid Biopsy for Promising Non-invasive Diagnostic Biomarkers in Parasitic Infections.
    Ozturk EA; Caner A
    Acta Parasitol; 2022 Mar; 67(1):1-17. PubMed ID: 34176040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liquid Biopsy in Oral Cancer.
    Lousada-Fernandez F; Rapado-Gonzalez O; Lopez-Cedrun JL; Lopez-Lopez R; Muinelo-Romay L; Suarez-Cunqueiro MM
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29890622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The functional and clinical roles of liquid biopsy in patient-derived models.
    Zhu Z; Hu E; Shen H; Tan J; Zeng S
    J Hematol Oncol; 2023 Apr; 16(1):36. PubMed ID: 37031172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liquid Biopsy: Approaches to Dynamic Genotyping in Cancer.
    von Bubnoff N
    Oncol Res Treat; 2017; 40(7-8):409-416. PubMed ID: 28693026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementing liquid biopsies into clinical decision making for cancer immunotherapy.
    Quandt D; Dieter Zucht H; Amann A; Wulf-Goldenberg A; Borrebaeck C; Cannarile M; Lambrechts D; Oberacher H; Garrett J; Nayak T; Kazinski M; Massie C; Schwarzenbach H; Maio M; Prins R; Wendik B; Hockett R; Enderle D; Noerholm M; Hendriks H; Zwierzina H; Seliger B
    Oncotarget; 2017 Jul; 8(29):48507-48520. PubMed ID: 28501851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating cell-free nucleic acids and platelets as a liquid biopsy in the provision of personalized therapy for lung cancer patients.
    Sorber L; Zwaenepoel K; Deschoolmeester V; Van Schil PE; Van Meerbeeck J; Lardon F; Rolfo C; Pauwels P
    Lung Cancer; 2017 May; 107():100-107. PubMed ID: 27180141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liquid Biopsies for Monitoring Temporal Genomic Heterogeneity in Breast and Colon Cancers.
    Venesio T; Siravegna G; Bardelli A; Sapino A
    Pathobiology; 2018; 85(1-2):146-154. PubMed ID: 28614831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liquid biopsy: a step forward towards precision medicine in urologic malignancies.
    Di Meo A; Bartlett J; Cheng Y; Pasic MD; Yousef GM
    Mol Cancer; 2017 Apr; 16(1):80. PubMed ID: 28410618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The liquid biopsy in the management of colorectal cancer patients: Current applications and future scenarios.
    Normanno N; Cervantes A; Ciardiello F; De Luca A; Pinto C
    Cancer Treat Rev; 2018 Nov; 70():1-8. PubMed ID: 30053724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.